PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 21 filers reported holding PARATEK PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $18,288,226 | +47.5% | 18,721,000 | +21.0% | 0.72% | +49.7% |
| Q1 2023 | $12,398,905 | -7.4% | 15,471,000 | 0.0% | 0.48% | -7.1% |
| Q4 2022 | $13,383,992 | -1.2% | 15,471,000 | 0.0% | 0.52% | 0.0% |
| Q3 2022 | $13,548,000 | +2.3% | 15,471,000 | 0.0% | 0.52% | -1.5% |
| Q2 2022 | $13,239,000 | +19.5% | 15,471,000 | +23.6% | 0.53% | +53.0% |
| Q1 2022 | $11,079,000 | +4.2% | 12,521,000 | +7.7% | 0.34% | +4.5% |
| Q4 2021 | $10,631,000 | +566.5% | 11,621,000 | +540.3% | 0.33% | +587.5% |
| Q3 2021 | $1,595,000 | -38.1% | 1,815,000 | -35.5% | 0.05% | -37.7% |
| Q2 2021 | $2,578,000 | – | 2,815,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PenderFund Capital Management Ltd. | 20,060,000 | $23,311,000 | 5.66% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 44,492,000 | $39,153,000 | 1.56% |
| UBS OCONNOR LLC | 26,000,000 | $23,448,000,000 | 0.34% |
| Saltoro Capital, LP | 750,000 | $678,000 | 0.17% |
| AQR Arbitrage LLC | 3,050,000 | $2,758,000 | 0.10% |
| WATER ISLAND CAPITAL LLC | 1,500,000 | $1,371,000 | 0.08% |
| PALISADE CAPITAL MANAGEMENT, LP | 3,448,000 | $3,103,000 | 0.07% |
| OAKTREE CAPITAL MANAGEMENT LP | 5,780,000 | $5,227,000 | 0.07% |
| Teton Advisors, Inc. | 400,000 | $358,000 | 0.05% |
| MACQUARIE GROUP LTD | 8,175,000 | $7,393,000 | 0.01% |